← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #97 OF 1,000 MOST-CITED

Lack of or inadequate final acceptance procedures

FDA cited this observation 232 times across 223 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices232
BY FISCAL YEAR
FY20264
FY202531
FY202421
FY202321
FY202212
FY20216
FY202021
FY201945
FY201838
FY201733

How FDA worded it — real examples

Procedures for finished device acceptance have not been adequately established.

Innova Vascular Inc · Irvine, California · Devices · 2026-01-12

Procedures for finished device acceptance have not been adequately established.

Osseofuse International Inc. · Las Vegas, Nevada · Devices · 2026-01-07

Procedures for finished device acceptance have not been adequately established.

Hatch Product Development LLC · Waukegan, Illinois · Devices · 2025-12-11

Procedures for finished device acceptance have not been established.

ASEPTIKITS, LLC · North Salt Lake, Utah · Devices · 2025-12-03

Procedures for finished device acceptance have not been adequately established.

Republic Spine, LLC · Fort Lauderdale, Florida · Devices · 2025-09-26

Procedures for finished device acceptance have not been adequately established.

Rudolf Storz GmbH · Emmingen-Liptingen · Devices · 2025-09-25

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemMedical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →